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ABSTRACT 
 
The cytotoxicity and mechanism of cell death induced by an extract of Ulmus davidiana 
Planch (UDP) were investigated. A 70 % ethanol extract of UDP exerted cytotoxic effects on 
HepG2 cells in a time- and dose-dependent manner caused a significant dose-dependent in-
crease in the number of apoptotic cells. In addition, obvious shrinkage and destruction of the 
monolayer were observed in UDP-treated cells, but not in untreated cells. RT-PCR analysis 
revealed that the mRNA expression of p53 and c-myc was markedly increased in cells treated 
with the plant extract. In contrast, caspase-3 expression was induced after 1 h of incubation 
and then decreased at 3 h; however, it subsequently increased and remained at a relatively 
high level thereafter. Our data suggest the presence of a bioactive compound capable of kill-
ing liver carcinoma cells by apoptosis in a 70 % ethanol extract of UDP, and that the mecha-
nism of apoptosis in the HepG2 cells included p53 and c-myc signaling. 
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INTRODUCTION 
 
Cancer is a serious clinical problem that 
poses significant social and economic chal-
lenges to the healthcare system. Despite 
improved imaging and molecular diagnostic 
techniques, cancer continues to affect mil-
lions of people globally (Eisenberg et al., 
1998). Hepatocellular carcinoma (HCC) is 
the fifth most common cancer and the third 
most common cause of cancer-related death 
(Parkin et al., 2001). In most cases, the re-
covery rate from HCC is low, and current 
conventional and modified therapies are 
rarely beneficial (Sheu, 1997; Thomas and 
Zhu, 2005). Thus, there is an urgent need 
for new therapeutic agents for HCC patients. 
A common means of drug discovery is the 
ethnomedical data approach, in which the 
selection of a plant is based on information 
related to its use as a folk medicine. A 
number of anti-cancer drugs have been ex-
tracted from plants, including paclitaxel 
(Matsuhashi et al., 2005), adriamycin 
(Hirao et al., 2004), etoposide (Baldwin and 
Osheroff, 2005), and camptothecin (Le-
garza and Yang, 2006). Apoptosis, as a 
physiological mode of cell death, may be 
mediated by the excess production of reac-
tive oxygen species (ROS) caused by ex-
ogenous and endogenous sources (Slater et 
al., 1963). Therefore, the search for agents 
that can trigger apoptosis in tumor cells has 
become a major goal in anti-cancer drug 
discovery (Reed, 2003).  
Ulmus davidiana Planch (UDP) is a de-
ciduous tree that is widely distributed 
throughout Korea. Its bark and roots are 
used in traditional oriental medicine to treat 
edema, mastitis, gastric cancer, and in-
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flammation (Kim, 2000). A number of bio-
logically active compounds has been iso-
lated from UDP, and their biological ac-
tions have been reported (Lee et al., 2001; 
Guo and Wang, 2007). For example, a gly-
coprotein isolated from UDP was shown to 
have strong antioxidant and anti-apoptotic 
effects (Lee et al., 2004).  
The aims of this study were to evaluate 
the cytotoxic properties of an extract pre-
pared from the bark of UDP and to deter-
mine the mechanism of cell death elicited 
by the extract in HCC cells. The human 
hepatoma HepG2 cell line is widely used as 
an experimental model for in vitro studies 
of HCC (Cheng et al., 2008). Thus, we in-
vestigated the effects of an ethanolic extract 
of UDP bark on HepG2 cells. 
 
MATERIALS AND METHODS 
 
Plant material and extract preparation  
Stems and bark from UDP plants were 
purchased from the Herbal Medicine 
Co-operative Association in Chuncheon, 
Korea. The bark samples were air-dried 
under shade at room temperature and pow-
dered. About 10 g of each powdered sample 
were then treated with 200 mL of water, 
ethanol, 70 % ethanol, methanol, 70 % 
methanol, or chloroform for 72 h. The ex-
tracts were then filtered, and the solvents 
were evaporated at 50 °C using a rotary 
evaporator. The recovery weight from the 
dried material was about 10 %. The extracts 
were dissolved in distilled water and sub-
sequently diluted to the appropriate work-
ing concentrations. 
 
Cell line and culture medium 
Human liver cancer HepG2 cells were 
maintained in RPMI 1640 medium con-
taining 10 % (v/v) heat-inactivated fetal 
bovine serum (FBS) supplemented with 
100 U/mL penicillin and 100 µg/mL strep-
tomycin at 37 °C under 5 % CO2 in air. 
 
MTT assay 
HepG2 cells were seeded in a 96-well 
plate at a concentration of 2 × 104 cells/mL 
using RPMI. After 16 h at 37 °C in a hu-
midified atmosphere of 5 % CO2, the ex-
tracts were applied to the wells at different 
concentrations. The cells were then incu-
bated for an additional 72 h at 37 °C. An 
MTT stock solution (50 µL of 2 mg/mL in 
PBS) was then added to each well for a to-
tal reaction volume of 250 µL. After 4 h of 
incubation at 37 °C in a humidified atmos-
phere of 5 % CO2, the plate was centrifuged 
at 800 x g for 5 min, and the supernatants 
were aspirated to remove all untransformed 
MTT. The formazan crystals in each well 
were then dissolved in 150 µL of DMSO. 
The amount of purple formazan was deter-
mined by measuring the absorbance at 
550 nm. For the treated cells, viability is 
expressed as the percentage of control cells.  
 
Trypan blue exclusion assay for cell viability 
After 24, 48, or 72 h of exposure, the 
medium was removed from the wells, and 
the cells were washed with 2 mL of sterile 
PBS. Next, 100 µL of 0.25 % trypsin were 
added, and the plates were incubated at 
37 °C for 5-10 min. Full growth medium 
(50 µL) and 0.4 % trypan blue (50 µL) were 
added to each well, and the plates were re-
turned to the incubator for another 5 min. 
Next, a 20 µL aliquot was removed and 
placed under a cover slip on a hemacy-
tometer, and the numbers of viable and 
nonviable cells were counted under a mi-
croscope. The number of viable cells was 
calculated using the following equation: UC 
× D × 104 / #SQ, where UC = the unstained 
cell count (viable cells), D = the dilution of 
the cell suspension, and #SQ = the number 
of squares on the hemacytometer that were 
counted. The percent viability for the popu-
lation on each Petri dish was calculated as: 
UC/TC × 100, where UC = the unstained 
cell count (viable cells) and TC = the total 
cell count (stained plus unstained cells). 
Each experiment was repeated four times. 
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Flow cytometry 
An Annexin V-FITC/PI Apoptosis De-
tection Kit (Becton-Dickinson, Franklin 
Lakes, NJ, USA) was used to detect apop-
tosis. Cells (5 × 105 per well) were seeded 
into six-well plates and then treated with 
varying concentrations of the 70 % ethanol 
extract. After 24 h of incubation, the cells 
were washed twice with ice-cold PBS 
(0.01 M, pH 7.2), and 100 µL of each sam-
ple were centrifuged at 200 x g for 5 min. 
The supernatant was then removed, and the 
cells were resuspended in 100 µL of An-
nexin V/FITC as per the manufacturer’s 
instructions. Apoptosis was monitored by 
FACScan flow cytometry (Becton-Dickin-
son). All Annexin V-positive, PI-negative 
cells were scored as apoptotic, while all 
double-stained cells were considered to be 
necrotic or late apoptotic (Wang et al., 
2006). 
 
Electron microscopy  
About 5 × 105 HepG2 cells were grown 
in 35-mm sterile Petri dishes in complete 
medium with or without 500 µg/mL 70 % 
ethanol extract of UDP for 48 h. The cells 
were then fixed for 5 min in 10 % metha-
nol/PBS before being analyzed for mor-
phological changes under an inverted mi-
croscope (Axiophot, Jena, Germany). 
 
Determination of the expression level of 
apoptosis-related genes 
The mRNA expression of three estab-
lished apoptosis-related genes (c-myc, p53, 
and caspase-3) was analyzed by 
semi-quantitative RT-PCR. The cells were 
cultured in T-25 flasks and then starved in 
medium containing 0.5 % (v/v) FCS for 4 h 
prior to stimulation. Total RNA was ex-
tracted from the untreated and treated cells 
using TRI-reagent® according to the 
manufacturer’s instructions (MRC, Cincin-
nati, OH, USA). First-strand cDNA was 
synthesized from 1 µg of the DNase-treated 
total RNA using AccuPower® PCR PreMix 
containing oligo(dT) primers and Moloney 
murine leukemia virus reverse transcriptase 
(M-MLV RT, Invitrogen, Carlsbad, CA, 
USA). The reactions were carried out as 
follows: 5 min of denaturation at 94 °C fol-
lowed by 30 cycles of 94 °C for 1 min, 
55 °C for 1 min, and 72 °C for 1 min with a 
final extension for 7 min at 72 °C. The se-
quences of the primers used herein were 
designed based on the human mRNAs en-
coded by the respective genes (Table 1). An 
aliquot of each RNA sample and 12 µL of 
each PCR product were separated on 1 % 
agarose gels and visualized by staining with 
ethidium bromide. All experiments were 
performed in triplicate.  
 
Calculations and statistics 
Cytotoxicity was analyzed in triplicate; 
the results are expressed as the percent 
growth inhibition with respect to the control. 
The data are given as the mean ± SEM. 
Gene expression at each time point was de-
termined by densitometric scanning using 
PhotocaptMw gel analysis software. The 
signals from c-myc, p53, and caspase-3 
were normalized to that from β-actin; the 
ratio in the unstimulated samples was de-
fined as 1. 
 
 
Table 1: The sequences of primers used in RT-PCR 
 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
c-myc  GAACAAGAAGATGAGGAAGA AGTTTGTGTTTCAACTGTTC 
p53 TGTGGAGTATTTGGATGACA GAACATGAGTTTTTTATGGC 
Caspase-3 TCACAGCAAAAGGAGCAGTTT CGTCAAAGGAAAAGGACTCAA 
β-Actin TCACCCTGAAGTACCCCATC CCATCTCTTGCTGCAAGTCC 
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RESULTS AND DISCUSSION 
 
Antiproliferative activity in various ex-
tracts of UDP  
In this study, the human liver cancer cell 
line HepG2 was used to examine the anti-
proliferative activity of UDP extracts. Cul-
tured HepG2 cells were treated with differ-
ent extracts of UDP at a concentration of 
0.5 mg/mL (Fig. 1). All extracts exerted an 
inhibitory effect on the cells; however, the 
70 % ethanol and ethanol extracts had the 
most significant effect.  
Figure 1: MTT assay of various extract of UDP 
on HepG2 liver cancer cells at the concentration 
of 500 µg/mL. Cells were treated with water, 
ethanol, 70 % ethanol, methanol, 70 % metha-
nol and chloroform extract of UDP for 48 h. 
Each data is expressed as the mean ± SD ob-
tained from triplicate experiments. 
 
The MTT assay is a method for quanti-
fying metabolically viable cells through 
their ability to reduce a soluble yellow 
tetrazolium salt to blue-purple formazan 
crystals (Mossman, 1983). By using 
96-well microtiter plates and a multi-well 
spectrophotometer (enzyme-linked immu-
nosorbent assay plate reader), the assay can 
be semiautomated in order to process a 
large number of samples and provide a 
rapid, objective measurement of cell num-
ber. 
 
Assessing cellular viability by trypan blue 
exclusion 
To determine the inhibitory effect of the 
70 % ethanol extract of UDP on human 
HepG2 cell growth, trypan blue exclusion 
analysis was used to assess the effect of 
UDP on cell viability (Fig. 2). Cell viability 
was evaluated by counting with a hemacy-
tometer. As shown in Fig. 1, UDP dramati-
cally inhibited HepG2 cell viability in a 
dose- and time-dependent manner. How-
ever, the cells showed varying levels of 
sensitivity to different concentrations of the 
extract, with increased susceptibility at a 
concentration of 200 µM. Incubation with 
50 to 100 µM UDP did not have an obvious 
inhibitory effect on HepG2 cell prolifera-
tion.  
 
Figure 2: Dose- and time-dependent cytotoxic-
ity of 70 % ethanol extract of UDP to HepG2 
cells. Cells were treated with 50, 100, 200, 500, 
and 1000 µg/ml of 70 % ethanol extract of UDP, 
respectively, for 24 (black circles), 48 (black 
squares) and 72 h (black triangles). Inhibition 
rate was expressed as cell death versus refer-
ence (cell viability = 100 %). Each data is ex-
pressed as the mean ± SD obtained from tripli-
cate experiments. 
 
There is evidence that most anti-cancer 
agents exert their cytotoxic effects by in-
ducing apoptosis in tumor cells (Kaufman, 
1989). Impairments in apoptosis are related 
to cell immortality, carcinogenesis, and the 
induction of apoptosis in neoplastic cells 
(Shinomiya et al., 1994); therefore, induc-
tion of apoptosis is vital in cancer treatment. 
Several chemotherapeutic drugs have been 
shown to induce apoptosis in vitro, includ-
ing etoposide, camptothecin, VM26, vin-
cristine, cis-platinum, cyclophosphamide, 
paclitaxel, 5-fluorouracil, and doxorubicin 
(Huschtscha et al., 1996). 
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Apoptotic effect of the UDP extract 
To further quantify the apoptotic effect of 
the 70 % ethanol extract of UDP, HepG2 
cells were stained with Annexin V-FITC 
and PI and subsequently analyzed by flow 
cytometry. The Annexin V assay monitors 
the turnover of phospholipids from the in-
ner to the outer layer of the plasma mem-
brane, an event typically associated with 
apoptosis. The proportion of Annexin 
V-stained cells was increased in the sam-
ple-treated cells (Fig. 3). After 48 h of 
treatment, the percentage of Annexin 
V-positive cells was 0.31 % for the controls 
(0.2 % DMSO), 18.56 % for the cells 
treated with 100 µg/mL 70  % ethanol ex-
tract, and 25.05 % for the cells treated with 
200 µg/mL 70 % ethanol extract. A signifi-
cant dose-dependent increase in the number 
of apoptotic HepG2 cells was detected for 
the cells treated with the 70 % ethanol ex-
tract. The quantitative analysis of phos-
phatidylserine externalization through An-
nexin V/FITC and PI staining indicated that 
the percentage of double-positive cells in 
late apoptosis was increased in a concentra-
tion-dependent manner after 48 h of treat-
ment with the 70 % ethanol extract. Our 
data indicate that the 70 % ethanol extract 
of UDP evoked apoptosis in the HepG2 
cells. 
 
Light microscopic observation 
To examine the effect of the 70 % ethanol 
extract on cellular morphology during cell 
death, the morphological changes in un-
treated HepG2 cells and cells treated with 
100, 200, or 500 µg/mL extract for 24 h 
were analyzed by light microscopy after 
trypan blue staining (Fig. 4). Compared to 
the untreated cells, the UDP-treated cells 
showed obvious cell shrinkage and destruc-
tion of the monolayer, which was not seen 
in the untreated cells. UDP treatment 
caused swelling in the HepG2 cells, result-
ing in condensed chromatin and a crooked 
membrane. A dose-dependent reduction in 
population size was also noted in the 
UDP-treated cells. 
 
Expression of apoptosis-related genes in 
the 70 % ethanol extract-treated cells 
To investigate the mechanism by which 
the 70 % extract induced apoptosis in 
HepG2 cells, the expression of several 
apoptosis-related genes, including p53, cas-
pase-3, and c-myc, was evaluated by 
RT-PCR with β-actin as an internal control. 
The steady-state level of p53 mRNA was 
increased drastically in the extract-treated 
cells after 1 h; however, it decreased there-
after (Fig. 5). The expression of caspase-3 
was induced after 1 h of incubation and de-
creased at 3 h; however, it later increased 
again and was maintained at a relatively 
high level thereafter. The level of c-myc 
mRNA was significantly increased at 1 h 
and reached its maximum at 3 h; it then de-
creased slightly but remained at a high level. 
Our results strongly indicate that the extract 
killed the HepG2 cells through apoptosis, 
mainly via the activation of p53 and c-myc.  
Figure 3: Flow cytometry analysis of 70 % ethanol extract of UDP induced apoptosis. Cells treated with 
100 and 500 µg/mL of samples, respectively, for 48 h. (A), control; (B-C) represent 100 and 500 µg/mL 
samples treated HepG2 cells, respectively. Results are representative of triplicate experiments. 
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Figure 4: Morphological changes of HepG2 cells under light and fluorescence microscope. HepG2 
cells were incubated for 48 h with 70 % ethanol extract of UDP. The medium was removed and the 
cells were rinsed and visualized under light microscope in control (A), 100 mg/L (B), 200 mg/L (C) and 
500 mg/L (D) of 70 % ethanol extract of UDP.  
 
 
Figure 5: (A) Time dependency effects of the 
p53, caspase-3 and c-myc mRNA levels in hu-
man liver cancer cell line, HepG2, incubated in 
the absence or presence of 70 % ethanol ex-
tract of UDP. β-Actin was used as an internal 
control for integrity and equal amount of cDNA 
used in each PCR reaction. (B) Graphical rep-
resentation of the expression profile of p53 
(black squares), caspase-3 (black diamonds) 
and c-myc (white diamonds) mRNA in HepG2 
cells following treatment with the extract. 
p53 is a major inhibitor of tumorigenesis. 
It stimulates a broad network of signals that 
act through two major apoptotic pathways: 
the extrinsic death receptor pathway, which 
triggers the activation of a caspase cascade, 
and the intrinsic mitochondrial pathway, 
which shifts the balance in the Bcl-2 family 
towards the pro-apoptotic members and, 
consequently, toward caspase-mediated 
apoptosis (Haupt et al., 2003). Myc is a 
co-activator of p53 that has been suggested 
to be an important determinant of the 
choice between p53-induced growth arrest 
or apoptosis (Hu and Kavanagh, 2003). 
Myc inhibits the growth arrest caused by 
UV light, γ-irradiation, and ROS-induced 
DNA damage (Sheen and Dickson, 2002). 
Caspases play an important role in 
apoptotic cell death. Caspase-3 is the most 
commonly activated caspase during apop-
tosis (Janicke et al., 1998). Caspase-3 has 
been widely shown to mediate the limited 
proteolysis of the structural protein gelsolin, 
p21-activated kinase 2 (PAK2), focal adhe-
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sion kinase (FAK), and rabaptin 5 (Tan et 
al., 2005). C-myc, a member of the Myc 
family of transcription factors, is a regulator 
of cell cycle progression and can induce 
apoptosis (Askew et al., 1991). 
In conclusion, our results strongly sug-
gest that a 70 % ethanol extract of UDP ex-
hibited significant cytotoxicity toward 
HepG2 liver cancer cells and that it may 
contain a bioactive compound capable of 
killing liver carcinoma cells by apoptosis 
through the activation of the p53 and c-myc 
pathways. Thus, U. davidiana should be 
considered as a functional food ingredient 
and pharmaceutical. However, the identifi-
cation of the individual compounds and in 
vivo experiments are needed to understand 
the mechanism of action.  
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